Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kiwamu Okita, Toshio Ohya et al.|European Journal of Cancer|2011Cited by 573